G. Bakris
Endocrinology, Diabetes and Metabolism · 2000–2024
A researcher in the Science corpus: 39 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 356 citations into it; #285 of 623 by trust here, #39 by citations
Whom G. Bakris trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Bakris overall
- V. Basevi
- S. Hyman
- S. Grundy
- A. Classification
- Massimo F. Piepoli
- T. Ivanova
- F. Turnbull
- I. Hirsch
- C. van Dijk
- J. Wright
Papers from G. Bakris's perspective
Ordered by how strongly the researchers G. Bakris trusts endorse each paper. Same corpus, a different order for every researcher.
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (New England Journal of Medicine)
- 10-year follow-up of intensive glucose control in type 2 diabetes. (New England Journal of Medicine)
- Prevalence and trends in obesity among US adults, 1999-2000. (Journal of the American Medical Association (JAMA))
- Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood (Clinical Chemistry and Laboratory Medicine)
- Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360,…
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
Their papers
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. (2024) — 1,097 citations
- Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) (2022) — 852 citations
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. (2021) — 2,063 citations
- 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. (2021) — 621 citations
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. (2021) — 1,134 citations
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. (2021) — 740 citations
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. (2020) — 1,916 citations
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. (2019) — 4,852 citations
- Resistant Hypertension: Detection, Evaluation, and Management (2018) — 839 citations
- Diabetes and Hypertension: A Position Statement by the American Diabetes Association (2017) — 649 citations
- Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis (2016) — 707 citations
- Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. (2015) — 612 citations
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. (2015) — 676 citations
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial. (2015) — 628 citations
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference (2014) — 1,110 citations
- Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety (2014) — 1,608 citations
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease (2013) — 938 citations
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes. (2013) — 2,419 citations
- ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. (2011) — 916 citations
- Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. (2011) — 619 citations